Gro Biosciences

Developer of re-coding synthetic biology tools

placeBoston, Massachusetts, United States calendar_todayFounded 2016 groups22 employees language grobio.com

Registered entities

Innovation

6 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 79 times.

YearFilings
20203
20212
20221
20231
20242
20251

Investor mix

13 investors on record; lead investors include Digitalis Ventures, Atlas Venture, Bayer, Redmile Group.

Investor typeCountShare
Venture capital969%
Other / undisclosed431%
Coming soon